Investor Overview
Skinvisible, Inc., through its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc., is a research and development pharmaceutical company that develops enhanced, patented dermatology and healthcare products. Its primary motivation and focus is to license its patented Invisicare formulations to national and international dermatological, medical, cosmetic, skincare and consumer goods manufacturers and distributors. Skinvisible also produces a variety of skincare products for private label clients.
Shareholder's Information:
Shares Outstanding Are: 95,609,009
Authorized: 200,000,000
Public Float: 55%
Insider Ownership: 45%
Fiscal Year End: December 31
July 27, 2010
Skinvisible's Invisicare Patent Portfolio Strengthens
- Hong Kong Patent Granted for Polymer Technology
July 20, 2010
Skinvisible Signs DermSafe Agreement for Europe and China
- RHEI Pharmaceuticals Adds Alcohol-Free Hand Sanitizer to Its Product Line
July 13, 2010
Skinvisible Licenses Invisicare Products for US, China and Europe
- Rhei Pharmaceuticals Receives Exclusivity for Three Skincare Formulations
April 13, 2010
Skinvisible Signs Development Agreement for Prescription Product for Women's Healthcare
- Women's Choice Pharmaceuticals chooses Invisicare for new products
CLICK HERE TO READ ALL NEWS RELEASES
|
Stock Information:
Go To Full SKVI Quote
OTC:SKVI at Google Finance
Press Releases
|
Skinvisible Web
PDF - 445k)